IRIDEX Corp
IRIX
View Detailed Chart
1.000USD
+0.030+3.09%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
17.05MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+3.09%
5 Days
+8.60%
1 Month
+6.38%
6 Months
+7.18%
Year to Date
-40.48%
1 Year
-39.02%
View Detailed Chart
TradingKey Stock Score of IRIDEX Corp
Currency: USD Updated: 2025-12-19Key Insights
IRIDEX Corp's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 150/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IRIDEX Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
IRIDEX Corp Highlights
StrengthsRisks
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Growing
The company is in a growing phase, with the latest annual income totaling USD 48.67M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 48.67M.
Fairly Valued
The company’s latest PE is -3.32, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.61M shares, decreasing 16.95% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 389.06K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.39.
IRIDEX Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
IRIDEX Corp Info
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Ticker SymbolIRIX
CompanyIRIDEX Corp
CEOMercer (Patrick)
Websitehttps://www.iridex.com/
FAQs
What is the current price of IRIDEX Corp (IRIX)?
The current price of IRIDEX Corp (IRIX) is 1.000.
What is the symbol of IRIDEX Corp?
The ticker symbol of IRIDEX Corp is IRIX.
What is the 52-week high of IRIDEX Corp?
The 52-week high of IRIDEX Corp is 1.890.
What is the 52-week low of IRIDEX Corp?
The 52-week low of IRIDEX Corp is 0.782.
What is the market capitalization of IRIDEX Corp?
The market capitalization of IRIDEX Corp is 17.05M.
What is the net income of IRIDEX Corp?
The net income of IRIDEX Corp is -8.91M.
Is IRIDEX Corp (IRIX) currently rated as Buy, Hold, or Sell?
According to analysts, IRIDEX Corp (IRIX) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of IRIDEX Corp (IRIX)?
The Earnings Per Share (EPS TTM) of IRIDEX Corp (IRIX) is -0.301.
Related Instruments
-0.24%
+0.25%
+0.87%
+1.88%
+0.22%
-0.55%
+0.53%
+0.12%
+1.35%
-0.10%
-1.23%
-0.77%
+0.10%
+0.46%
+0.46%
+0.97%
+0.59%
+0.23%
+0.45%
+1.74%
